An Anti-Gravity Active Device for Exoskeletons to Reduce the Impact of Work-Related Musculoskeletal Disorders in the Logistics, Retailing and Manufacturing Sectors.broad
AGADE(Anti-Gravity Active Device for Exoskeletons) · Horizon Europe grant · 2022-09-01–2025-03-31
EC contribution
Total cost
Beneficiaries
About the data
Source: CORDIS (official EU open data), Horizon Europe. Framework HORIZON · call HORIZON-EIC-2021-ACCELERATOROPEN-01 · scheme HORIZON-EIC-ACC-BF · topic HORIZON-EIC-2021-ACCELERATOROPEN-01. CORDIS record →
Objective
We introduce a disruptive, patented motion technology for exoskeletons: AGADE. It relies on a hybrid (active+passive) proprietary actuation system designed to reduce by 10 times electric consumption (compared to common electric motors) and, proportionally, batteries and motors’ weight. AGADE aims at erasing work-related muscular disorders through AGADEXO, the first exoskeleton to combine lightness, comfort and low environmental impact with smart compensation of physical fatigue at work. It is conceived of as a modular product (shoulder, low-back and full-body modules) in order to increase customisation and maximise market coverage and penetration in different sectors, such as logistics, retailing and manufacturing. Our innovation disrupts the market by bringing to it high-tech devices so far impossible to commercialise. The innovative wearable robotic system of AGADEXO does not substitute the individual, but it empowers physical abilities, improves efficiency and satisfaction at work.
Beneficiaries (1)
| Organisation | Country | Role | EC contribution | SME |
|---|---|---|---|---|
| AGADE SRL | IT | coordinator | €1,820,106 | Yes |
Get the DFM funding briefing — free
New EU defence calls, tenders and awards in your inbox.
Defence Finance Monitor is an analytical and informational product. Grant data is official CORDIS; payment and subscription happen on DFM Analysis.